Wolfgang Wienen - Concepedia

Author

Wolfgang Wienen

Boehringer Ingelheim (Germany)

Also Known As

Jean-Marie Stassen, Martin Feuring, W Wienen, W. WIENEN, W. Wienen, Wolfgang Wienen

Publications

5.1K

Citations

H-Index

Concepts

All Affiliations

Boehringer Ingelheim (Germany)University of Applied Sciences Biberach Pharmazeutische Fabrik Dr. Reckeweg (Germany)Max Delbrück Center Jeffrey Modell Foundation

About

Wolfgang Wienen is an author at Boehringer Ingelheim (Germany) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	21	1.9K
2	Biochemistry	7	7	811
3	Natural Sciences	6	6	728
4	Public Health	1	1	27
5	Biomolecular Engineering	1	1	20

Wolfgang Wienen

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
Structure-Based Design of Novel Potent Nonpeptide Thrombin Inhibitors Norbert Hauel, Herbert Nar, Henning Priepke, Journal of Medicinal Chemistry Chemical BiologyPharmaceutical ChemistryThrombosisMedicinal ChemistryThrombin Inhibition	2002	448
The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226 K Rudolf, Wolfgang Eberlein, Wolfhard Engel, European Journal of Pharmacology Functional SelectivityMedicineG Protein-coupled ReceptorNeuropeptide ReceptorNeuropharmacology	1994	374
6-Substituted benzimidazoles as new nonpeptide angiotensin II receptor antagonists: synthesis, biological activity, and structure-activity relationships Uwe J. Ries, Gerhard Mihm, Berthold Narr, Journal of Medicinal Chemistry Biological ActivityMedicinal ChemistryBibr 277Drug TargetBiochemistry	1993	199
Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277 Wolfgang Wienen, Norbert Hauel, J. C. A. van Meel, British Journal of Pharmacology HypertensionPharmacological CharacterizationCardiovascular PharmacologyRenal InflammationPharmacotherapy	1993	192
AT1 Receptor Antagonist Telmisartan Administered Peripherally Inhibits Central Responses to Angiotensin II in Conscious Rats Peter Gohlke, S Weiss, Anita Jansen, Journal of Pharmacology and Experimental Therapeutics	2001	128
Pharmacological characterization of the selective nonpeptide neuropeptide Y Y1 receptor antagonist BIBP 3226. Henri Doods, Wolfgang Wienen, Michael Entzeroth, Journal of Pharmacology and Experimental Therapeutics	1995	127
Angiotensin II receptor blockade in TGR(mREN2)27: effects of renin???angiotensin-system gene expression and cardiovascular functions Manfred B hm, MinAe Lee, Reinhold Kreutz, Journal of Hypertension	1995	99
Adrenomedullin mediates vasodilation via CGRP1 receptors Michael Entzeroth, Henri Doods, H. Wieland, Life Sciences Adrenal GlandSignal TransductionMolecular PhysiologyMedicinePhysiology	1994	85
Dabigatran Acylglucuronide, the Major Human Metabolite of Dabigatran: In Vitro Formation, Stability, and Pharmacological Activity Ebner Thomas, Klaus Wagner, Wolfgang Wienen Drug Metabolism and Disposition	2010	84
Subtype selectivity and antagonistic profile of the nonpeptide Y1 receptor antagonist BIBP 3226. H. Wieland, Klaus‐Dieter Willim, Michael Entzeroth, Journal of Pharmacology and Experimental Therapeutics	1995	84

Page 1